DMTK - DermTech signs contracts with Highmark for the foundational assay of its melanoma test
2023-09-19 09:23:23 ET
More on DermTech
- Seeking Alpha’s Quant Rating on DermTech
- Historical earnings data for DermTech
- Financial information for DermTech
- DermTech, Inc. (DMTK) Q2 2023 Earnings Call Transcript
- DermTech announces restructuring to focus on its Melanoma Test, lays off 15% of workforce
For further details see:
DermTech signs contracts with Highmark for the foundational assay of its melanoma test